Effect of interleukin 13 on bronchial hyperresponsiveness and the bronchoprotective effect of beta-adrenergic bronchodilators and corticosteroids.

[1]  Christopher M. Tan,et al.  Adenovirus IL-13-induced airway disease in mice: a corticosteroid-resistant model of severe asthma. , 2008, American journal of respiratory cell and molecular biology.

[2]  A. Wanner,et al.  The effect of corticosteroids on the disposal of long-acting beta2-agonists by airway smooth muscle cells. , 2007, The Journal of allergy and clinical immunology.

[3]  Richard J Martin,et al.  Airway remodeling and lack of bronchodilator response in steroid-resistant asthma. , 2007, The Journal of allergy and clinical immunology.

[4]  R. Townley.  Interleukin 13 and the beta-adrenergic blockade theory of asthma revisited 40 years later. , 2007, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[5]  S. Wenzel,et al.  Allergen-dependent solubilization of IL-13 receptor alpha2 reveals a novel mechanism to regulate allergy. , 2007, The Journal of allergy and clinical immunology.

[6]  R. Townley,et al.  Effect of Fluticasone and/or β-agonists on Airway Hyperresponsiveness (AHR) In Mice Either Sensitized to Allergen or Pre-treated with IL-13 , 2007 .

[7]  G. Rodrigo.  Rapid effects of inhaled corticosteroids in acute asthma: an evidence-based evaluation. , 2006, Chest.

[8]  I. Adcock,et al.  Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. , 2006, American journal of respiratory and critical care medicine.

[9]  M. Lomask.  Further exploration of the Penh parameter. , 2006, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[10]  P. Barnes.  How corticosteroids control inflammation: Quintiles Prize Lecture 2005 , 2006, British journal of pharmacology.

[11]  B. Ma,et al.  Role of CCR5 in the Pathogenesis of IL-13-Induced Inflammation and Remodeling1 , 2006, The Journal of Immunology.

[12]  Richard J Martin,et al.  Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma. , 2006, American journal of respiratory and critical care medicine.

[13]  I. Adcock,et al.  Update on glucocorticoid action and resistance. , 2006, The Journal of allergy and clinical immunology.

[14]  M. Wills-Karp,et al.  Interleukin‐13 in asthma pathogenesis , 2004, Immunological reviews.

[15]  Steven M. Miller,et al.  Modulation of calcium signaling by interleukin-13 in human airway smooth muscle: role of CD38/cyclic adenosine diphosphate ribose pathway. , 2004, American journal of respiratory cell and molecular biology.

[16]  A. Adler,et al.  Unrestrained plethysmography is an unreliable measure of airway responsiveness in BALB/c and C57BL/6 mice. , 2004, Journal of applied physiology.

[17]  M. Michel,et al.  Effect of prednisolone and ketotifen onβ2-adrenoceptors in asthmatic patients receivingβ2-bronchodilators , 2004, European Journal of Clinical Pharmacology.

[18]  Anthony W. Norman,et al.  Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model , 2004, Nature Reviews Drug Discovery.

[19]  R. Townley,et al.  Airway hyperresponsiveness , 2003, Clinical reviews in allergy & immunology.

[20]  木部 敦子.  Differential regulation by glucocorticoid of interleukin-13-induced eosinophilia, hyperresponsiveness, and goblet cell hyperplasia in mouse airways , 2003 .

[21]  M. W. Jensen,et al.  Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5'-monophosphate in mild asthma. , 2002, The Journal of allergy and clinical immunology.

[22]  S. Shore,et al.  Effects of cytokines on contractile and dilator responses of airway smooth muscle , 2002, Clinical and experimental pharmacology & physiology.

[23]  D. Sheppard,et al.  Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma , 2002, Nature Medicine.

[24]  M. Grunstein,et al.  IL-13-dependent autocrine signaling mediates altered responsiveness of IgE-sensitized airway smooth muscle. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[25]  V. Casolaro,et al.  Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism. , 2001, American journal of respiratory cell and molecular biology.

[26]  E. Silverman,et al.  The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. , 2000, American journal of respiratory and critical care medicine.

[27]  T. Mosmann,et al.  Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. , 1999, Journal of immunology.

[28]  K. Chung,et al.  Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma. , 1999, American journal of respiratory and critical care medicine.

[29]  D D Donaldson,et al.  Interleukin-13: central mediator of allergic asthma , 1998 .

[30]  D B Corry,et al.  Requirement for IL-13 independently of IL-4 in experimental asthma. , 1998, Science.

[31]  T. Lee,et al.  Airway smooth muscle as a target of glucocorticoid action in the treatment of asthma. , 1998, American journal of respiratory and critical care medicine.

[32]  K. Shirato,et al.  Dexamethasone suppresses gene expression and production of IL-13 by human mast cell line and lung mast cells. , 1998, The Journal of allergy and clinical immunology.

[33]  C. Rodrigo,et al.  Inhaled flunisolide for acute severe asthma. , 1998, American journal of respiratory and critical care medicine.

[34]  Lipworth.  β2‐adrenoceptor responsiveness and asthma activity , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[35]  A. Kagey‐Sobotka,et al.  Corticosteroid modulation of human, antigen-specific Th1 and Th2 responses. , 1997, The Journal of allergy and clinical immunology.

[36]  I. Hall,et al.  Systemic corticosteriod rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients. , 1997, American journal of respiratory and critical care medicine.

[37]  R. Martin,et al.  Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. , 1997, American journal of respiratory and critical care medicine.

[38]  S. U. Rahman,et al.  In vivo quantification of human pulmonary beta-adrenoceptors: effect of beta-agonist therapy. , 1996, American journal of respiratory and critical care medicine.

[39]  S. Szefler,et al.  A novel action of IL-13: induction of diminished monocyte glucocorticoid receptor-binding affinity. , 1996, Journal of immunology.

[40]  J. M. Cousin,et al.  Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. , 1996, Journal of immunology.

[41]  D. Agrawal,et al.  Immunopharmacology of allergic diseases , 1996 .

[42]  R. Martin,et al.  Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma , 1995, The Journal of experimental medicine.

[43]  P. Barnes,et al.  Glucocorticosteroids increase beta 2-adrenergic receptor transcription in human lung. , 1995, The American journal of physiology.

[44]  P. Barnes,et al.  A Comparison of β-Adrenergic Receptors and In Vitro Relaxant Responses to Isoproterenol in Asthmatic Airway Smooth Muscle , 1992 .

[45]  P. Henricks,et al.  Mechanisms of beta-adrenergic receptor regulation in lungs and its implications for physiological responses. , 1992, Physiological reviews.

[46]  D. Tashkin,et al.  Reversal of human lymphocyte β‐adrenoceptor desensitization by glucocorticoids , 1982 .

[47]  R. Townley,et al.  Effect of hydrocortisone on beta-adrenergic receptors in lung membranes. , 1979, Life sciences.